Empowered Funds LLC Raises Holdings in Humana Inc. (NYSE:HUM)

Empowered Funds LLC increased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 164.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,914 shares of the insurance provider's stock after buying an additional 9,264 shares during the period. Empowered Funds LLC's holdings in Humana were worth $4,724,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in HUM. Pzena Investment Management LLC lifted its holdings in shares of Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after acquiring an additional 1,955,375 shares during the last quarter. Marshall Wace LLP boosted its holdings in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock worth $532,564,000 after purchasing an additional 774,085 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of Humana by 261,025.1% during the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock valued at $2,340,660,000 after purchasing an additional 738,701 shares during the last quarter. Steadfast Capital Management LP bought a new position in shares of Humana during the 1st quarter valued at about $158,813,000. Finally, Baupost Group LLC MA purchased a new position in shares of Humana during the 2nd quarter valued at about $156,933,000. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Royal Bank of Canada decreased their price target on shares of Humana from $400.00 to $265.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Stephens reiterated an "equal weight" rating and issued a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. Piper Sandler lowered shares of Humana from an "overweight" rating to a "neutral" rating and cut their price target for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. UBS Group decreased their price objective on Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, October 4th. Finally, JPMorgan Chase & Co. boosted their target price on Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research note on Wednesday, August 21st. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Humana presently has an average rating of "Hold" and an average price target of $315.86.

Humana Stock Down 1.6 %

Shares of Humana stock traded down $4.32 during trading on Monday, hitting $271.35. The company's stock had a trading volume of 1,929,765 shares, compared to its average volume of 1,875,254. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a market capitalization of $32.67 billion, a PE ratio of 24.42, a P/E/G ratio of 2.17 and a beta of 0.52. The company has a fifty day simple moving average of $281.36 and a two-hundred day simple moving average of $331.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts predict that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Tuesday, December 31st. Humana's payout ratio is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.